ARCA biopharma (ABIO) Stock Chart & Stock Price History → Gold Mania (From Stansberry Research) (Ad) Free ABIO Stock Alerts $3.26 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ARCA biopharma Stock Price Performance5 Day Performance-8.94%1 Month Performance+0.31%3 Month Performance+101.23%6 Month Performance+71.46%Year-To-Date Performance+91.76%1 Year Performance+55.24% Receive ABIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. ABIO Stock Chart for Saturday, May, 4, 2024 ABIO Chart by TradingView ARCA biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$3.26$3.26$3.46$3.2516,945 shs$47.29 million05/02/2024$3.25$3.26+0.31%$3.35$3.2066,022 shs$47.30 million05/01/2024$3.49$3.25-6.88%$3.50$3.18155,833 shs$47.16 million04/30/2024$3.43$3.49+1.75%$3.58$3.34214,422 shs$50.64 million04/29/2024$3.58$3.43-4.19%$3.60$3.42229,892 shs$49.77 million04/26/2024$3.48$3.58+2.87%$3.68$3.5085,281 shs$51.91 million Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$3.63$3.48-4.13%$3.66$3.4153,994 shs$50.46 million04/24/2024$3.65$3.63-0.55%$3.73$3.6097,712 shs$52.64 million04/23/2024$3.45$3.65+5.80%$3.75$3.45211,794 shs$52.93 million04/22/2024$3.40$3.45+1.47%$3.48$3.30294,919 shs$50.03 million04/19/2024$3.25$3.40+4.62%$3.42$3.21922,511 shs$49.30 million04/18/2024$3.21$3.25+1.25%$3.32$3.13218,431 shs$47.13 million04/17/2024$3.27$3.21-1.83%$3.31$3.1395,037 shs$46.55 million04/16/2024$3.18$3.27+2.83%$3.31$3.13294,950 shs$47.42 million04/15/2024$3.23$3.18-1.55%$3.27$3.15134,500 shs$46.11 million04/12/2024$3.25$3.23-0.62%$3.31$3.15351,248 shs$46.84 million04/11/2024$3.14$3.25+3.50%$3.27$3.10153,785 shs$47.13 million04/10/2024$3.13$3.14+0.32%$3.19$3.01212,915 shs$45.53 million04/09/2024$3.00$3.13+4.33%$3.33$2.98570,607 shs$45.39 million04/08/2024$3.09$3.00-2.91%$3.10$2.95600,901 shs$43.50 million04/05/2024$3.08$3.09+0.32%$3.18$2.95587,056 shs$44.81 million04/04/2024$3.25$3.08-5.23%$3.14$2.902.74 million shs$44.66 million04/03/2024$1.71$3.25+90.06%$3.88$2.8880.76 million shs$47.13 million04/02/2024$1.75$1.71-2.29%$1.75$1.6912,636 shs$24.80 million04/01/2024$1.76$1.75-0.57%$1.78$1.7515,352 shs$25.38 million03/29/2024$1.76$1.76$1.77$1.739,002 shs$25.52 million03/28/2024$1.75$1.76+0.57%$1.77$1.739,001 shs$25.52 million03/27/2024$1.71$1.75+2.34%$1.75$1.697,276 shs$25.38 million03/26/2024$1.73$1.71-1.16%$1.73$1.6928,574 shs$24.80 million03/25/2024$1.77$1.73-2.26%$1.78$1.7140,182 shs$25.09 million03/22/2024$1.78$1.77-0.56%$1.78$1.7511,152 shs$25.67 million03/21/2024$1.75$1.78+1.71%$1.80$1.7150,583 shs$25.81 million03/20/2024$1.74$1.75+0.57%$1.75$1.705,202 shs$25.38 million03/19/2024$1.72$1.74+1.16%$1.74$1.6558,061 shs$25.23 million03/18/2024$1.69$1.72+1.78%$1.72$1.6839,825 shs$24.94 million03/15/2024$1.70$1.69-0.59%$1.73$1.6846,812 shs$24.51 million03/14/2024$1.69$1.70+0.59%$1.70$1.6659,564 shs$24.65 million03/13/2024$1.66$1.69+1.81%$1.69$1.6619,299 shs$24.51 million03/12/2024$1.65$1.66+0.91%$1.67$1.6029,937 shs$24.07 million03/11/2024$1.64$1.65+0.30%$1.65$1.6013,103 shs$23.85 million$21,000 in profits in six weeks? (Ad)On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details.03/08/2024$1.63$1.63$1.66$1.5815,920 shs$23.64 million03/07/2024$1.66$1.63-1.81%$1.71$1.6132,938 shs$23.64 million03/06/2024$1.67$1.66-0.60%$1.69$1.668,333 shs$24.07 million03/05/2024$1.68$1.67-0.60%$1.68$1.6247,673 shs$24.22 million03/04/2024$1.67$1.68+0.60%$1.75$1.6220,644 shs$24.36 million03/01/2024$1.63$1.67+2.45%$1.69$1.639,818 shs$24.22 million02/29/2024$1.67$1.63-2.40%$1.68$1.6110,890 shs$23.64 million02/28/2024$1.69$1.67-1.18%$1.72$1.6522,027 shs$24.22 million02/27/2024$1.65$1.69+2.42%$1.69$1.6225,068 shs$24.51 million02/26/2024$1.63$1.65+1.23%$1.68$1.6114,725 shs$23.93 million02/23/2024$1.63$1.63$1.65$1.614,573 shs$23.64 million02/22/2024$1.63$1.63+0.20%$1.64$1.6012,026 shs$23.64 million02/21/2024$1.64$1.63-0.51%$1.66$1.5764,674 shs$23.59 million02/20/2024$1.67$1.64-2.10%$1.67$1.6212,414 shs$23.71 million02/19/2024$1.67$1.67$1.67$1.6216,700 shs$24.22 million02/16/2024$1.65$1.67+1.21%$1.67$1.6216,715 shs$24.22 million02/15/2024$1.64$1.65+0.61%$1.65$1.6013,476 shs$23.93 million02/14/2024$1.60$1.64+2.50%$1.64$1.6024,971 shs$23.78 million02/13/2024$1.66$1.60-3.61%$1.65$1.6042,413 shs$23.20 million02/12/2024$1.66$1.66$1.68$1.6613,322 shs$24.07 million02/09/2024$1.65$1.66+0.61%$1.68$1.6519,959 shs$24.07 million02/08/2024$1.60$1.65+3.12%$1.69$1.6350,995 shs$23.93 million02/07/2024$1.59$1.60+0.63%$1.65$1.5817,436 shs$23.20 million02/06/2024$1.60$1.59-0.63%$1.61$1.5826,595 shs$23.06 million02/05/2024$1.62$1.60-1.23%$1.62$1.6013,254 shs$23.20 million02/02/2024$1.58$1.62+2.54%$1.65$1.5742,459 shs$0.00 Related Companies: Aspira Women's Health Stock Price Chart ImmuCell Stock Price Chart VolitionRx Stock Price Chart Alpha Teknova Stock Price Chart OncoCyte Stock Price Chart Cardio Diagnostics Stock Price Chart Trinity Biotech Stock Price Chart Achieve Life Sciences Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Zepp Health Stock Price Chart Receive ABIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABIO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.